Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Plomgaard, AM; Alderliesten, T; van, Bel, F; Benders, M; Claris, O; Cordeiro, M; Dempsey, E; Fumagalli, M; Gluud, C; Hyttel-Sorensen, S; Lemmers, P; Pellicer, A; Pichler, G; Greisen, G.
No neurodevelopmental benefit of cerebral oximetry in the first randomised trial (SafeBoosC II) in preterm infants during the first days of life.
Acta Paediatr. 2019; 108(2):275-281
Doi: 10.1111/apa.14463
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Pichler Gerhard
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- AIM: Cerebral hypoxia has been associated with neurodevelopmental impairment. We studied whether reducing cerebral hypoxia in extremely preterm infants during the first 72 hours of life affected neurological outcomes at two years of corrected age. METHODS: In 2012-2013, the phase II randomised Safeguarding the Brains of our smallest Children trial compared visible cerebral near-infrared spectroscopy (NIRS) monitoring in an intervention group and blinded NIRS monitoring in a control group. Cerebral hypoxia was significantly reduced in the intervention group. We followed up 115 survivors from eight European centres at two years of corrected age, by conducting a medical examination and assessing their neurodevelopment with the Bayley Scales of Infant and Toddler Development, Second or Third Edition, and the parental Ages and Stages Questionnaire (ASQ). RESULTS: There were no differences between the intervention (n = 65) and control (n = 50) groups with regard to the mean mental developmental index (89.6 ± 19.5 versus 88.4 ± 14.7, p = 0.77), ASQ score (215 ± 58 versus 213 ± 58, p = 0.88) and the number of children with moderate-to-severe neurodevelopmental impairment (10 versus six, p = 0.58). CONCLUSION: Cerebral NIRS monitoring was not associated with long-term benefits or harm with regard to neurodevelopmental outcome at two years of corrected age.
- Find related publications in this database (using NLM MeSH Indexing)
- Child, Preschool - administration & dosage
- Female - administration & dosage
- Humans - administration & dosage
- Hypoxia, Brain - diagnosis, therapy
- Infant, Extremely Premature - administration & dosage
- Infant, Newborn - administration & dosage
- Male - administration & dosage
- Neurodevelopmental Disorders - prevention & control
- Oximetry - methods
- Spectroscopy, Near-Infrared - administration & dosage
- Find related publications in this database (Keywords)
- Ages and stages questionnaire
- Bayley scales of infant and toddler development
- Cerebral near-infrared spectroscopy
- Extremely preterm infants
- Neurodevelopment